Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 9 of 9 entries
Sorted by: Best Match Show Resources per page
Response to Intervention with Older Students with Reading Difficulties.

Learning and individual differences

Vaughn S, Fletcher JM, Francis DJ, Denton CA, Wanzek J, Wexler J, Cirino PT, Barth AE, Romain MA.
PMID: 19129920
Learn Individ Differ. 2008;18(3):338-345. doi: 10.1016/j.lindif.2008.05.001.

Addressing the literacy needs of secondary school students involves efforts to raise the achievement levels of all students and to address specifically the needs of struggling readers. One approach to this problem is to consider the application of a...

Cite
Vaughn S, Fletcher JM, Francis DJ, et al. Response to Intervention with Older Students with Reading Difficulties. Learn Individ Differ. 2008;18(3):338-345doi: 10.1016/j.lindif.2008.05.001.
Vaughn, S., Fletcher, J. M., Francis, D. J., Denton, C. A., Wanzek, J., Wexler, J., Cirino, P. T., Barth, A. E., & Romain, M. A. (2008). Response to Intervention with Older Students with Reading Difficulties. Learning and individual differences, 18(3), 338-345. https://doi.org/10.1016/j.lindif.2008.05.001
Vaughn, Sharon, et al. "Response to Intervention with Older Students with Reading Difficulties." Learning and individual differences vol. 18,3 (2008): 338-345. doi: https://doi.org/10.1016/j.lindif.2008.05.001
Vaughn S, Fletcher JM, Francis DJ, Denton CA, Wanzek J, Wexler J, Cirino PT, Barth AE, Romain MA. Response to Intervention with Older Students with Reading Difficulties. Learn Individ Differ. 2008;18(3):338-345. doi: 10.1016/j.lindif.2008.05.001. PMID: 19129920; PMCID: PMC2614270.
Copy Download .nbib Format: NLM
Effects of Individualized and Standardized Interventions on Middle School Students With Reading Disabilities.

Exceptional children

Vaughn S, Wexler J, Roberts G, Barth AA, Cirino PT, Romain MA, Francis D, Fletcher J, Denton CA.
PMID: 23125463
Except Child. 2011 May;77(4):391-407. doi: 10.1177/001440291107700401.

This study reports the effectiveness of a year-long, small-group, tertiary (Tier 3) intervention that examined 2 empirically derived but conceptually different treatments and a comparison condition. The researchers had randomly assigned all students to treatment or comparison conditions. The...

Cite
Vaughn S, Wexler J, Roberts G, et al. Effects of Individualized and Standardized Interventions on Middle School Students With Reading Disabilities. Except Child. 2011;77(4):391-407doi: 10.1177/001440291107700401.
Vaughn, S., Wexler, J., Roberts, G., Barth, A. A., Cirino, P. T., Romain, M. A., Francis, D., Fletcher, J., & Denton, C. A. (2011). Effects of Individualized and Standardized Interventions on Middle School Students With Reading Disabilities. Exceptional children, 77(4), 391-407. https://doi.org/10.1177/001440291107700401
Vaughn, Sharon, et al. "Effects of Individualized and Standardized Interventions on Middle School Students With Reading Disabilities." Exceptional children vol. 77,4 (2011): 391-407. doi: https://doi.org/10.1177/001440291107700401
Vaughn S, Wexler J, Roberts G, Barth AA, Cirino PT, Romain MA, Francis D, Fletcher J, Denton CA. Effects of Individualized and Standardized Interventions on Middle School Students With Reading Disabilities. Except Child. 2011 May;77(4):391-407. doi: 10.1177/001440291107700401. PMID: 23125463; PMCID: PMC3485696.
Copy Download .nbib Format: NLM
Reading skill components and impairments in middle school struggling readers.

Reading and writing

Cirino PT, Romain MA, Barth AE, Tolar TD, Fletcher JM, Vaughn S.
PMID: 24000271
Read Writ. 2013 Aug;26(7):1059-1086. doi: 10.1007/s11145-012-9406-3.

This study investigated how measures of decoding, fluency, and comprehension in middle school students overlap with one another, whether the pattern of overlap differs between struggling and typical readers, and the relative frequency of different types of reading difficulties....

Cite
Cirino PT, Romain MA, Barth AE, et al. Reading skill components and impairments in middle school struggling readers. Read Writ. 2013;26(7):1059-1086doi: 10.1007/s11145-012-9406-3.
Cirino, P. T., Romain, M. A., Barth, A. E., Tolar, T. D., Fletcher, J. M., & Vaughn, S. (2013). Reading skill components and impairments in middle school struggling readers. Reading and writing, 26(7), 1059-1086. https://doi.org/10.1007/s11145-012-9406-3
Cirino, Paul T, et al. "Reading skill components and impairments in middle school struggling readers." Reading and writing vol. 26,7 (2013): 1059-1086. doi: https://doi.org/10.1007/s11145-012-9406-3
Cirino PT, Romain MA, Barth AE, Tolar TD, Fletcher JM, Vaughn S. Reading skill components and impairments in middle school struggling readers. Read Writ. 2013 Aug;26(7):1059-1086. doi: 10.1007/s11145-012-9406-3. PMID: 24000271; PMCID: PMC3757546.
Copy Download .nbib Format: NLM
Safety and Tolerability of Manual Push Administration of Subcutaneous IgPro20 at High Infusion Rates in Patients with Primary Immunodeficiency: Findings from the Manual Push Administration Cohort of the HILO Study.

Journal of clinical immunology

Cowan J, Bonagura VR, Lugar PL, Maglione PJ, Patel NC, Vinh DC, Hofmann JH, Praus M, Rojavin MA.
PMID: 33025378
J Clin Immunol. 2021 Jan;41(1):66-75. doi: 10.1007/s10875-020-00876-6. Epub 2020 Oct 06.

PURPOSE: To evaluate the safety and tolerability of IgPro20 manual push (also known as rapid push) infusions at flow rates of 0.5-2.0 mL/min.METHODS: Patients with primary immunodeficiency (PID) with previous experience administering IgPro20 (HizentraRESULTS: Sixteen patients were treated; 2...

Cite
Cowan J, Bonagura VR, Lugar PL, et al. Safety and Tolerability of Manual Push Administration of Subcutaneous IgPro20 at High Infusion Rates in Patients with Primary Immunodeficiency: Findings from the Manual Push Administration Cohort of the HILO Study. J Clin Immunol. 2020;41(1):66-75doi: 10.1007/s10875-020-00876-6.
Cowan, J., Bonagura, V. R., Lugar, P. L., Maglione, P. J., Patel, N. C., Vinh, D. C., Hofmann, J. H., Praus, M., & Rojavin, M. A. (2021). Safety and Tolerability of Manual Push Administration of Subcutaneous IgPro20 at High Infusion Rates in Patients with Primary Immunodeficiency: Findings from the Manual Push Administration Cohort of the HILO Study. Journal of clinical immunology, 41(1), 66-75. https://doi.org/10.1007/s10875-020-00876-6
Cowan, Juthaporn, et al. "Safety and Tolerability of Manual Push Administration of Subcutaneous IgPro20 at High Infusion Rates in Patients with Primary Immunodeficiency: Findings from the Manual Push Administration Cohort of the HILO Study." Journal of clinical immunology vol. 41,1 (2021): 66-75. doi: https://doi.org/10.1007/s10875-020-00876-6
Cowan J, Bonagura VR, Lugar PL, Maglione PJ, Patel NC, Vinh DC, Hofmann JH, Praus M, Rojavin MA. Safety and Tolerability of Manual Push Administration of Subcutaneous IgPro20 at High Infusion Rates in Patients with Primary Immunodeficiency: Findings from the Manual Push Administration Cohort of the HILO Study. J Clin Immunol. 2021 Jan;41(1):66-75. doi: 10.1007/s10875-020-00876-6. Epub 2020 Oct 06. PMID: 33025378; PMCID: PMC7846525.
Copy Download .nbib Format: NLM
Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema.

Allergy & rhinology (Providence, R.I.)

Craig T, Shapiro R, Vegh A, Baker JW, Bernstein JA, Busse P, Magerl M, Martinez-Saguer I, Riedl MA, Lumry W, Williams-Herman D, Edelman J, Feuersenger H, Machnig T, Rojavin M.
PMID: 28381322
Allergy Rhinol (Providence). 2017 Mar 01;8(1):13-19. doi: 10.2500/ar.2017.8.0192.

BACKGROUND: The plasma-derived, pasteurized, nanofiltered C1-inhibitor concentrate (pnfC1-INH) is approved in the United States as an intravenous (IV) on-demand treatment for hereditary angioedema (HAE) attacks, and, in Europe, as on demand and short-term prophylaxis.OBJECTIVE: This analysis evaluated Berinert Patient...

Cite
Craig T, Shapiro R, Vegh A, et al. Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema. Allergy Rhinol (Providence). 2017;8(1):13-19doi: 10.2500/ar.2017.8.0192.
Craig, T., Shapiro, R., Vegh, A., Baker, J. W., Bernstein, J. A., Busse, P., Magerl, M., Martinez-Saguer, I., Riedl, M. A., Lumry, W., Williams-Herman, D., Edelman, J., Feuersenger, H., Machnig, T., & Rojavin, M. (2017). Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema. Allergy & rhinology (Providence, R.I.), 8(1), 13-19. https://doi.org/10.2500/ar.2017.8.0192
Craig, Timothy, et al. "Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema." Allergy & rhinology (Providence, R.I.) vol. 8,1 (2017): 13-19. doi: https://doi.org/10.2500/ar.2017.8.0192
Craig T, Shapiro R, Vegh A, Baker JW, Bernstein JA, Busse P, Magerl M, Martinez-Saguer I, Riedl MA, Lumry W, Williams-Herman D, Edelman J, Feuersenger H, Machnig T, Rojavin M. Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema. Allergy Rhinol (Providence). 2017 Mar 01;8(1):13-19. doi: 10.2500/ar.2017.8.0192. PMID: 28381322; PMCID: PMC5380447.
Copy Download .nbib Format: NLM
Enhancing Patient Flexibility of Subcutaneous Immunoglobulin G Dosing: Pharmacokinetic Outcomes of Various Maintenance and Loading Regimens in the Treatment of Primary Immunodeficiency.

Biologics in therapy

Sidhu J, Rojavin M, Pfister M, Edelman J.
PMID: 25118975
Biol Ther. 2014 Dec;4(1):41-55. doi: 10.1007/s13554-014-0018-0. Epub 2014 Aug 14.

INTRODUCTION: Standard treatment for patients with primary immunodeficiency (PID) is monthly intravenous immunoglobulin (IVIG), or weekly/biweekly subcutaneous immunoglobulin (SCIG) infusion. We used population pharmacokinetic modeling to predict immunoglobulin G (IgG) exposure following a broad range of SCIG dosing regimens...

Cite
Sidhu J, Rojavin M, Pfister M, et al. Enhancing Patient Flexibility of Subcutaneous Immunoglobulin G Dosing: Pharmacokinetic Outcomes of Various Maintenance and Loading Regimens in the Treatment of Primary Immunodeficiency. Biol Ther. 2014;4(1):41-55doi: 10.1007/s13554-014-0018-0.
Sidhu, J., Rojavin, M., Pfister, M., & Edelman, J. (2014). Enhancing Patient Flexibility of Subcutaneous Immunoglobulin G Dosing: Pharmacokinetic Outcomes of Various Maintenance and Loading Regimens in the Treatment of Primary Immunodeficiency. Biologics in therapy, 4(1), 41-55. https://doi.org/10.1007/s13554-014-0018-0
Sidhu, Jagdev, et al. "Enhancing Patient Flexibility of Subcutaneous Immunoglobulin G Dosing: Pharmacokinetic Outcomes of Various Maintenance and Loading Regimens in the Treatment of Primary Immunodeficiency." Biologics in therapy vol. 4,1 (2014): 41-55. doi: https://doi.org/10.1007/s13554-014-0018-0
Sidhu J, Rojavin M, Pfister M, Edelman J. Enhancing Patient Flexibility of Subcutaneous Immunoglobulin G Dosing: Pharmacokinetic Outcomes of Various Maintenance and Loading Regimens in the Treatment of Primary Immunodeficiency. Biol Ther. 2014 Dec;4(1):41-55. doi: 10.1007/s13554-014-0018-0. Epub 2014 Aug 14. PMID: 25118975; PMCID: PMC4254869.
Copy Download .nbib Format: NLM
Civilian nuclear incidents: An overview of historical, medical, and scientific aspects.

Journal of emergencies, trauma, and shock

Rojavin Y, Seamon MJ, Tripathi RS, Papadimos TJ, Galwankar S, Kman N, Cipolla J, Grossman MD, Marchigiani R, Stawicki SP.
PMID: 21769214
J Emerg Trauma Shock. 2011 Apr;4(2):260-72. doi: 10.4103/0974-2700.82219.

Given the increasing number of operational nuclear reactors worldwide, combined with the continued use of radioactive materials in both healthcare and industry, the unlikely occurrence of a civilian nuclear incident poses a small but real danger. This article provides...

Cite
Rojavin Y, Seamon MJ, Tripathi RS, et al. Civilian nuclear incidents: An overview of historical, medical, and scientific aspects. J Emerg Trauma Shock. 2011;4(2):260-72doi: 10.4103/0974-2700.82219.
Rojavin, Y., Seamon, M. J., Tripathi, R. S., Papadimos, T. J., Galwankar, S., Kman, N., Cipolla, J., Grossman, M. D., Marchigiani, R., & Stawicki, S. P. (2011). Civilian nuclear incidents: An overview of historical, medical, and scientific aspects. Journal of emergencies, trauma, and shock, 4(2), 260-72. https://doi.org/10.4103/0974-2700.82219
Rojavin, Yuri, et al. "Civilian nuclear incidents: An overview of historical, medical, and scientific aspects." Journal of emergencies, trauma, and shock vol. 4,2 (2011): 260-72. doi: https://doi.org/10.4103/0974-2700.82219
Rojavin Y, Seamon MJ, Tripathi RS, Papadimos TJ, Galwankar S, Kman N, Cipolla J, Grossman MD, Marchigiani R, Stawicki SP. Civilian nuclear incidents: An overview of historical, medical, and scientific aspects. J Emerg Trauma Shock. 2011 Apr;4(2):260-72. doi: 10.4103/0974-2700.82219. PMID: 21769214; PMCID: PMC3132367.
Copy Download .nbib Format: NLM
Animal models for the study of osteomyelitis.

Seminars in plastic surgery

Patel M, Rojavin Y, Jamali AA, Wasielewski SJ, Salgado CJ.
PMID: 20567737
Semin Plast Surg. 2009 May;23(2):148-54. doi: 10.1055/s-0029-1214167.

Osteomyelitis is an acute or chronic inflammatory process of the bone and its related structures secondary to an infection with pyogenic organisms. Because of the variety in disease presentations and pathophysiology of osteomyelitis, it is very difficult to evaluate...

Cite
Patel M, Rojavin Y, Jamali AA, et al. Animal models for the study of osteomyelitis. Semin Plast Surg. 2009;23(2):148-54doi: 10.1055/s-0029-1214167.
Patel, M., Rojavin, Y., Jamali, A. A., Wasielewski, S. J., & Salgado, C. J. (2009). Animal models for the study of osteomyelitis. Seminars in plastic surgery, 23(2), 148-54. https://doi.org/10.1055/s-0029-1214167
Patel, Mitul, et al. "Animal models for the study of osteomyelitis." Seminars in plastic surgery vol. 23,2 (2009): 148-54. doi: https://doi.org/10.1055/s-0029-1214167
Patel M, Rojavin Y, Jamali AA, Wasielewski SJ, Salgado CJ. Animal models for the study of osteomyelitis. Semin Plast Surg. 2009 May;23(2):148-54. doi: 10.1055/s-0029-1214167. PMID: 20567737; PMCID: PMC2884898.
Copy Download .nbib Format: NLM
Safety and Tolerability of Subcutaneous IgPro20 at High Infusion Parameters in Patients with Primary Immunodeficiency: Findings from the Pump-Assisted Administration Cohorts of the HILO Study.

Journal of clinical immunology

Anderson JT, Bonagura VR, Cowan J, Hsu C, Mustafa SS, Patel NC, Routes JM, Sriaroon P, Vinh DC, Hofmann JH, Praus M, Rojavin MA.
PMID: 33409867
J Clin Immunol. 2021 Feb;41(2):458-469. doi: 10.1007/s10875-020-00912-5. Epub 2021 Jan 06.

PURPOSE: To evaluate the safety and tolerability of subcutaneous IgPro20 (HizentraMETHODS: The HizentraRESULTS: Responder rates were 86.7% (13/15, 25 mL) and 73.3% (11/15, 40 and 50 mL) in the Volume Cohort, and 77.8% (14/18, 25 and 50 mL/h), 66.7%...

Cite
Anderson JT, Bonagura VR, Cowan J, et al. Safety and Tolerability of Subcutaneous IgPro20 at High Infusion Parameters in Patients with Primary Immunodeficiency: Findings from the Pump-Assisted Administration Cohorts of the HILO Study. J Clin Immunol. 2021;41(2):458-469doi: 10.1007/s10875-020-00912-5.
Anderson, J. T., Bonagura, V. R., Cowan, J., Hsu, C., Mustafa, S. S., Patel, N. C., Routes, J. M., Sriaroon, P., Vinh, D. C., Hofmann, J. H., Praus, M., & Rojavin, M. A. (2021). Safety and Tolerability of Subcutaneous IgPro20 at High Infusion Parameters in Patients with Primary Immunodeficiency: Findings from the Pump-Assisted Administration Cohorts of the HILO Study. Journal of clinical immunology, 41(2), 458-469. https://doi.org/10.1007/s10875-020-00912-5
Anderson, John T, et al. "Safety and Tolerability of Subcutaneous IgPro20 at High Infusion Parameters in Patients with Primary Immunodeficiency: Findings from the Pump-Assisted Administration Cohorts of the HILO Study." Journal of clinical immunology vol. 41,2 (2021): 458-469. doi: https://doi.org/10.1007/s10875-020-00912-5
Anderson JT, Bonagura VR, Cowan J, Hsu C, Mustafa SS, Patel NC, Routes JM, Sriaroon P, Vinh DC, Hofmann JH, Praus M, Rojavin MA. Safety and Tolerability of Subcutaneous IgPro20 at High Infusion Parameters in Patients with Primary Immunodeficiency: Findings from the Pump-Assisted Administration Cohorts of the HILO Study. J Clin Immunol. 2021 Feb;41(2):458-469. doi: 10.1007/s10875-020-00912-5. Epub 2021 Jan 06. PMID: 33409867; PMCID: PMC7858210.
Copy Download .nbib Format: NLM
Showing 1 to 9 of 9 entries